A formulator adds the exact dose the study used. The product still fails its claim. The error was not the dose that went in — it was forgetting everything that happens to that dose between the mixing tank and the consumer.
Inclusion rate — how much of an active ingredient goes into a formulation — looks like simple arithmetic. The clinical study used 200 mg; add 200 mg; claim the benefit. In practice, this is where a surprising number of functional products quietly fail, because the dose that matters is not the one added at blending. It is the one remaining, active and bioavailable, in the product the consumer actually consumes at the end of its shelf life.
Modeling inclusion rate properly means working backward from the claim through every loss the dose will suffer — and building in the margin to survive them.
The losses between tank and consumer
A dose added at blending is eroded by a predictable series of losses, each of which must be estimated and accounted for:
- Processing loss. Heat, shear, and exposure during manufacturing degrade many actives. A heat-sensitive vitamin can lose a substantial fraction during pasteurization or extrusion.
- Shelf-life loss. Even a stable-looking product loses active over time. The dose at the end of the stated shelf life is always lower than the dose at production.
- Overage and analytical margin. Real-world batch-to-batch variation and assay tolerance mean the formulation must aim above the target, not at it.
- Bioavailability. For some claims, what matters is not the dose present but the dose the body can actually use — and the form of the ingredient determines that.
Three failure patterns recur:
- The label-true-at-zero product. The dose is correct on production day, meets the claim, and then drops below threshold halfway through shelf life. Every unit sold after that point carries a false claim.
- The cost-cut that broke the claim. To protect margin, the inclusion rate is set right at the claim threshold with no overage. Normal processing and shelf-life losses then carry it under, and the claim quietly fails.
- The wrong-form dose. The right number of milligrams is added, but in a form with lower bioavailability than the studied one — so the effective dose is below what the claim requires even on day one.
The discipline that makes claims hold: model the inclusion rate backward from the end-of-shelf-life, bioavailable dose the claim requires — then add overage for processing loss, shelf-life decay, and analytical variation. The number you add at blending is always higher than the number on the label.
Questions before setting an inclusion rate
- What is the end-of-shelf-life dose the claim actually requires — not the day-of-production dose?
- What are the expected processing losses for this active in your specific process?
- What is the shelf-life decay curve, confirmed by real-time stability data?
- Is the ingredient form the same one the claim's evidence is based on, with the same bioavailability?
- Does the inclusion rate include overage for batch variation and analytical tolerance — or is it set right at the edge?
Where a sourcing partner adds value
Inclusion-rate modeling is exactly where ingredient sourcing meets formulation reality — and where a technical partner protects both the claim and the cost. That means estimating processing and shelf-life losses for a specific active in a specific process, not in the abstract; confirming the ingredient form matches the one the evidence is based on; modeling the overage needed so the end-of-life dose holds the claim with margin; and balancing all of that against cost, because over-dosing wastes money just as under-dosing breaks claims.
The art is finding the inclusion rate that is high enough to hold the claim through shelf life and no higher — and that requires knowing both the molecule and the process intimately.
The takeaway
The dose that matters is the one left at the end, not the one added at the start. Model every inclusion rate backward from the end-of-shelf-life, bioavailable dose your claim requires, add overage for processing and decay, and confirm your ingredient form matches the evidence. Do that and your claim holds in every unit, all the way to the last day on the shelf — which is the only place it actually has to.
This article is provided for general informational purposes and reflects industry practice. It is not technical, regulatory, or legal advice for any specific product or jurisdiction. Formulation and compliance decisions should be validated with qualified specialists.
